American Family Children's Hospital
Ricardo V. Lloyd, MD close
Ricardo V. Lloyd, MD

For Patients

Need help selecting a doctor?
Call the Welcome Center at
(608) 821-4819 for personal assistance.

For Referring Physicians

How to refer a patient

Ricardo V. Lloyd, MD Print Friendly Page

Dr. Lloyd earned his medical degree from the University of Wisconsin School of Medicine and Public Health and completed his residency at University of Wisconsin Hospital and Clinics.  He also completed his fellowship at University of Wisconsin Hospital and Clinics and Memorial Sloan-Kettering Cancer Center.  Dr. Lloyd is board certified in anatomic & clinical pathology and molecular genetic pathology.



UW Health Clinics

Pathology Clinic
University Hospital
(608) 263-8437 | (800) 323-8942 | Map

Hospital Affiliation(s)

University Hospital (primary)

UW School of Medicine and Public Health

Department of Pathology and Laboratory Medicine

Professional Certifications and Education

Board Certification Anatomic Pathology & Clinical Pathology
Molecular Genetic Pathology
Fellowship University of Wisconsin Hospital and Clinics, Madison, WI
Memorial Sloan-Kettering Cancer Center, New York, NY
Residency University of Wisconsin Hospital and Clinics, Madison, WI
Medical School University of Wisconsin School of Medicine and Public Health, Madison, WI, 1975

Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.
PubMed Articles
Yu XM Jaskula-Sztul R Georgen MR Aburjania Z Somnay YR Leverson G Sippel RS Lloyd RV Johnson BP Chen H . Notch1 Signaling Regulates the Aggressiveness of Differentiated Thyroid Cancer and Inhibits SERPINE1 Expression. Clin Cancer Res. 2016 Feb 4;
[PubMed ID: 26847059]
Zhang R Hardin H Chen J Guo Z Lloyd RV . Non-Coding RNAs in Thyroid Cancer. Endocr Pathol. 2016 Feb 4;
[PubMed ID: 26847830]
Papathomas TG Pucci E Giordano TJ Lu H Duregon E Volante M Papotti M Lloyd RV Tischler AS van Nederveen FH Nose V Erickson L Mete O Asa SL Turchini J Gill AJ Matias-Guiu X Skordilis K Stephenson TJ Tissier F Feelders RA Smid M Nigg A Korpershoek E van der Spek PJ Dinjens WN Stubbs AP de Krijger RR . An International Ki67 Reproducibility Study in Adrenal Cortical Carcinoma. Am J Surg Pathol. 2015 Dec 17;
[PubMed ID: 26685085]
Rosenbaum JN Guo Z Baus RM Werner H Rehrauer WM Lloyd RV . INSM1: A Novel Immunohistochemical and Molecular Marker for Neuroendocrine and Neuroepithelial Neoplasms. Am J Clin Pathol. 2015 Oct;144(4):579-91
[PubMed ID: 26386079]
Guo Z Lloyd RV . Pheochromocytomas and Paragangliomas: An Update on Recent Molecular Genetic Advances and Criteria for Malignancy. Adv Anat Pathol. 2015 Sep;22(5):283-93
[PubMed ID: 26262510]
Guo Z Hardin H Montemayor-Garcia C Asioli S Righi A Maletta F Sapino A Lloyd RV . In Situ Hybridization Analysis of miR-146b-5p and miR-21 in Thyroid Nodules: Diagnostic Implications. Endocr Pathol. 2015 May;26(2):157-63
[PubMed ID: 25771986]
Schneider DF Elfenbein D Lloyd RV Chen H Sippel RS . Lymph node metastases do not impact survival in follicular variant papillary thyroid cancer. Ann Surg Oncol. 2015 Jan;22(1):158-63
[PubMed ID: 25092163]
Jin L Lloyd RV Henry MR Erickson LA Sebo TJ Rumilla KM Zhang J . The diagnostic utility of combination of HMGA2 and IMP3 qRT-PCR testing in thyroid neoplasms. Appl Immunohistochem Mol Morphol. 2015 Jan;23(1):36-43
[PubMed ID: 25356939]
Rosenbaum JN Lloyd RV . Pancreatic Neuroendocrine Neoplasms. Surg Pathol Clin. 2014 Dec;7(4):559-75
[PubMed ID: 26837555]
Hsu KT Yu XM Audhya AW Jaume JC Lloyd RV Miyamoto S Prolla TA Chen H . Novel approaches in anaplastic thyroid cancer therapy. Oncologist. 2014 Nov;19(11):1148-55
[PubMed ID: 25260367]
Hardin H Guo Z Shan W Montemayor-Garcia C Asioli S Yu XM Harrison AD Chen H Lloyd RV . The roles of the epithelial-mesenchymal transition marker PRRX1 and miR-146b-5p in papillary thyroid carcinoma progression. Am J Pathol. 2014 Aug;184(8):2342-54
[PubMed ID: 24946010]
Asioli S Righi A Volante M Chiusa L Lloyd RV Bussolati G . Cell size as a prognostic factor in oncocytic poorly differentiated carcinomas of the thyroid. Hum Pathol. 2014 Jul;45(7):1489-95
[PubMed ID: 24745614]
Murray SE Lloyd RV Sippel RS Chen H Oltmann SC . Postoperative surveillance of small appendiceal carcinoid tumors. Am J Surg. 2014 Mar;207(3):342-5; discussion 345
[PubMed ID: 24393285]
Montemayor-Garcia C Hardin H Guo Z Larrain C Buehler D Asioli S Chen H Lloyd RV . The role of epithelial mesenchymal transition markers in thyroid carcinoma progression. Endocr Pathol. 2013 Dec;24(4):206-12
[PubMed ID: 24126800]
Hardin H Montemayor-Garcia C Lloyd RV . Thyroid cancer stem-like cells and epithelial-mesenchymal transition in thyroid cancers. Hum Pathol. 2013 Sep;44(9):1707-13
[PubMed ID: 23528862]
Murray SE Lloyd RV Sippel RS Chen H . Clinicopathologic characteristics of colonic carcinoid tumors. J Surg Res. 2013 Sep;184(1):183-8
[PubMed ID: 23830363]
Lloyd RV Hardin H Montemayor-Garcia C Rotondo F Syro LV Horvath E Kovacs K . Stem cells and cancer stem-like cells in endocrine tissues. Endocr Pathol. 2013 Mar;24(1):1-10
[PubMed ID: 23435637]
Gertz R Sarda R Lloyd R . Follicular thyroid carcinoma presenting as a massive chest wall tumor. Endocr Pathol. 2013 Mar;24(1):20-4
[PubMed ID: 23229718]
Buehler D Hardin H Shan W Montemayor-Garcia C Rush PS Asioli S Chen H Lloyd RV . Expression of epithelial-mesenchymal transition regulators SNAI2 and TWIST1 in thyroid carcinomas. Mod Pathol. 2013 Jan;26(1):54-61
[PubMed ID: 22899291]
Murray SE Sippel RS Lloyd R Chen H . Surveillance of small rectal carcinoid tumors in the absence of metastatic disease. Ann Surg Oncol. 2012 Oct;19(11):3486-90
[PubMed ID: 22707111]